% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Sha:278348,
author = {S. Sha$^*$ and L.-J. Chen$^*$ and H. Brenner$^*$ and B.
Schöttker$^*$},
title = {{A}ssociations of 25-hydroxyvitamin {D} status and vitamin
{D} supplementation use with mortality due to 18 frequent
cancer types in the {UK} {B}iobank cohort.},
journal = {European journal of cancer},
volume = {191},
issn = {0014-2964},
address = {Amsterdam [u.a.]},
publisher = {Elsevier},
reportid = {DKFZ-2023-01605},
pages = {113241},
year = {2023},
note = {#EA:C070#LA:C070#},
abstract = {Although the associations of serum 25-hydroxyvitamin D
(25(OH)D) levels and vitamin D supplementation with total
cancer mortality are well-known, evidence regarding the
association of 25(OH)D and cancer site-specific mortality is
predominantly limited to common cancer types, and most
studies on vitamin D supplementation use have limitations on
sample size and the adjustment of important confounding
factors.We used cause-specific Cox regression models
adjusted for 48 covariates to assess the associations of
vitamin D deficiency, insufficiency, and vitamin D
supplementation use with mortality from any cancer and 18
specific cancers in 411,436 United Kingdom Biobank
participants, aged 40-69 years.The majority of the study
population had either vitamin D deficiency $(21.1\%)$ or
insufficiency $(34.4\%).$ Furthermore, $4.1\%$ and $20.3\%$
of the participants regularly took vitamin D or multivitamin
supplements, respectively. During a median follow-up of 12.7
years, vitamin D deficiency was associated with
significantly increased mortality from total cancer and four
specific cancers: stomach (hazard ratio, $95\%$ confidence
interval: 1.42, 1.05-1.92), colorectal (1.27, 1.07-1.50),
lung (1.24, 1.10-1.40), and prostate (1.36, 1.06-1.75).
Vitamin D insufficiency was associated with increased
colorectal (1.14, 1.00-1.30) and lung cancer mortality
(1.19, 1.08-1.32). Compared to non-users, vitamin D use was
associated with lower lung cancer (0.75, 0.60-0.95) and
total cancer mortality. Multivitamin use was associated with
lower mortality from melanoma (0.64, 0.43-0.97).Vitamin D
deficiency and insufficiency were associated with increased
mortality from multiple common cancers. The potential to
reduce cancer mortality by vitamin D supplementation in
populations with low 25(OH)D levels should be further
explored.},
keywords = {Cancer site-specific mortality (Other) / Real-world
evidence (Other) / Serum 25-hydroxyvitamin D levels (Other)
/ Vitamin D supplement use (Other)},
cin = {C070 / C120 / HD01},
ddc = {610},
cid = {I:(DE-He78)C070-20160331 / I:(DE-He78)C120-20160331 /
I:(DE-He78)HD01-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37549530},
doi = {10.1016/j.ejca.2023.113241},
url = {https://inrepo02.dkfz.de/record/278348},
}